FibroGen to Release 2024 Financial Results Soon FibroGen, a biopharmaceutical company, is set to announce its fourth-quarter and full-year 2024 financial results on March 17, 2025. The company will host a webcast and conference call to discuss its performance and provide updates on its ongoing projects, including treatments for anemia and metastatic prostate cancer.1